Viewing nowCrown Tablet 10 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Daewon Biotech Co., Ltd.

MFDS item code 201906900 · Approved 2019.09.30 · Insurance code 057600310
Treatment of dyslipidemia, inhibition of atherosclerosis progression, prevention of cardiovascular disease
This medication is used as an adjunct when diet and exercise alone are insufficient to control primary hypercholesterolemia and mixed dyslipidemia. It also helps reduce LDL cholesterol levels in patients with familial hypercholesterolemia when used in conjunction with diet or other treatments. It can maintain total cholesterol and LDL cholesterol levels at target levels in patients with hypercholesterolemia, thereby delaying the progression of atherosclerosis. It is also used as an adjunct in pediatric and adolescent patients who meet specific criteria for heterozygous familial hypercholesterolemia. Furthermore, it is effective in reducing the risk of stroke, myocardial infarction, and revascularization procedures in adults at high risk for cardiovascular disease. This medication is utilized to improve dyslipidemia and related disorders.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. Adjust the maintenance dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 3. Elderly patients: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on administration of doses greater than 20 milligrams in pediatric patients.) Adjust the dose individually according to the recommended treatment goal for each patient. Adjust the dose at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For instance, it should not be administered to patients who are allergic to it, those with active liver disease, those with muscle disorders, patients with severe renal impairment, pregnant or breastfeeding women, and women of childbearing age who are not using appropriate contraception. This medication may affect liver function; patients with a history of liver disease or excessive alcohol intake should have regular liver function tests. Additionally, if symptoms of muscle pain or weakness occur, they should consult a physician immediately, and in severe cases, they may need to discontinue the medication. While taking this medication, there may be interactions with other drugs, so any medications being taken must be disclosed to healthcare providers. In particular, the risk of muscle-related side effects may increase when used in combination with certain antiviral agents, immunosuppressants, and fibrate drugs. Pregnant or breastfeeding women should not take this medication, and women who can become pregnant should employ adequate contraception methods. If pregnancy is confirmed, the medication should be stopped immediately. In case of overdose, there is no specific antidote, and management should be based on symptoms along with liver function and muscle enzyme tests. This medication may rarely cause serious skin reactions, liver damage, kidney abnormalities, or neurological issues, so patients should consult healthcare providers immediately if unusual symptoms occur. Also, caution is advised while driving or operating machinery as dizziness may occur during the use of this medication.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, systemic pain
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture, at temperatures between 1 and 30 degrees Celsius. Proper storage can prolong the effectiveness of the medication.
Pink round film-coated tablet
28 tablets/box [14 tablets/PTP X 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Daewon Biotech Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.